ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,338,000 | +71.3% | 221,871 | +2.3% | 0.00% | +100.0% |
| Q3 2019 | $781,000 | +46.8% | 216,851 | +9.3% | 0.00% | 0.0% |
| Q2 2019 | $532,000 | -8.1% | 198,416 | +1.4% | 0.00% | 0.0% |
| Q1 2019 | $579,000 | +83.8% | 195,599 | -1.4% | 0.00% | 0.0% |
| Q4 2018 | $315,000 | -38.5% | 198,304 | +42.5% | 0.00% | 0.0% |
| Q3 2018 | $512,000 | +28.0% | 139,190 | -1.5% | 0.00% | 0.0% |
| Q2 2018 | $400,000 | -21.1% | 141,268 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $507,000 | +35.9% | 136,678 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $373,000 | -47.2% | 129,388 | -17.8% | 0.00% | -50.0% |
| Q3 2017 | $707,000 | -1.5% | 157,396 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $718,000 | +20.3% | 156,416 | +10.3% | 0.00% | +100.0% |
| Q1 2017 | $597,000 | +9.9% | 141,759 | +7.7% | 0.00% | 0.0% |
| Q4 2016 | $543,000 | -47.1% | 131,585 | +3.9% | 0.00% | -66.7% |
| Q3 2016 | $1,026,000 | +6.1% | 126,621 | +2.1% | 0.00% | 0.0% |
| Q2 2016 | $967,000 | +4.5% | 124,017 | +3.5% | 0.00% | 0.0% |
| Q1 2016 | $925,000 | -27.1% | 119,859 | +2.0% | 0.00% | -25.0% |
| Q4 2015 | $1,268,000 | +78.1% | 117,525 | +14.0% | 0.00% | +100.0% |
| Q3 2015 | $712,000 | -21.5% | 103,100 | +0.7% | 0.00% | -33.3% |
| Q2 2015 | $907,000 | -33.0% | 102,422 | -25.4% | 0.00% | -25.0% |
| Q1 2015 | $1,354,000 | -6.0% | 137,352 | +16.8% | 0.00% | 0.0% |
| Q4 2014 | $1,441,000 | +33.2% | 117,622 | +8.5% | 0.00% | +33.3% |
| Q3 2014 | $1,082,000 | +33.9% | 108,417 | +1.6% | 0.00% | +50.0% |
| Q2 2014 | $808,000 | +210.8% | 106,737 | +35.2% | 0.00% | +100.0% |
| Q1 2014 | $260,000 | -6.5% | 78,920 | -5.6% | 0.00% | 0.0% |
| Q4 2013 | $278,000 | -1.4% | 83,630 | -10.4% | 0.00% | 0.0% |
| Q3 2013 | $282,000 | -61.5% | 93,364 | +4.3% | 0.00% | -50.0% |
| Q2 2013 | $732,000 | – | 89,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |